TetraQ is the commercial arm of the Centre for Integrated preclinical Drug Development (CIPDD) at the University of Queensland based in Brisbane, Australia.
Since 2005 TetraQ operates as an independent CRO offering a fully integrated range of high-quality, preclinical testing services to the global pharmaceutical, , biotechnology and nutraceutical industries. Its accredited laboratories and quality system successfully passed audits by clients and national and international regulatory authorities and accreditation bodies.
Best of Both Worlds
Operating a commercial and regulatory compliant preclinical CRO from within a leading university has proven to provide the best of both worlds as CIPDD’s primary focus is applied preclinical drug development which provides an invaluable resource of deep scientific expertise and high-tech capabilities accessible to TetraQ.
This has enabled TetraQ to go beyond traditional preclinical testing services and gain experience with a variety of molecules, biologics and monoclonal antibodies as well as having collaborations with researchers in the fields of high-throughput screening, pharmacogenomics, bioinformatics, medicinal chemistry and related disciplines to assist clients in evaluating and validating new leads.
TetraQ has consolidated its scientific operations across two locations in Brisbane, Australia, and has representation in Japan, Europe, and USA.
TetraQ, a registered business of Uniquest Pty Limited ACN 010 529 898, a company duly incorporated under the laws of Australia and having its principal place of business at Level 7, GP South Building, Staff House Road, The University of Queensland, St. Lucia, in the State of Queensland, 4072 Australia (“TetraQ”).